Project Synapse
Transforming Clinical Trials with AI-Driven Precision
THE PROBLEM
LAGGING AI CAPABILITIES LEFT CLIENT VULNERABLE THEY NEEDED A STRATEGY & A SYSTEM TO COMPETE
A medical software client partnered with Digineer to integrate AI across their internal web platform - giving Contract Research Organizations (CROs) powerful, actionable insights that accelerate drug development and dramatically improve trial performance.
-
THE BREAKTHROUGH
A proprietary AI solution that delivers real-time performance metrics, personalized site-level insights, and predictive analytics - modernizing the system and positioning the client as a category leader in the clinical software space.
RESULTS | INSIGHTS THAT MOVE THE MARKET
· 129% Faster: Top-performing clinical site moved more than twice as fast as the lowest-performing site, insight uncovered and activated by AI
· 188% Improvement Potential: One low-performing site had the ability to drastically improve record quality compared to peers, once identified through the model
· Thousands of metrics, visualizations, and forecasts - delivered in real time, without manual lift
THIS WASN’T JUST AI FOR THE SAKE OF INNOVATION - IT WAS AI THAT RESHAPED PERFORMANCE ACROSS HUNDREDS OF TRIALS.
STRATEGIC CONSULTING.
PRAGMATIC AI.
REAL RESULTS.
THE CHALLENGE: INNOVATION URGENCY MEETS EXECUTION ROADBLOCKS
The clients leadership team recognized they were falling behind in AI enablement, and risked losing market share in a space where speed, efficiency, and data intelligence are everything.
KEY BARRIERS:
Falling Behind the Curve: Intranet lacked the AI capabilities competitors were already touting
No Strategic Starting Point: Leaders weren’t sure how to prioritize use cases or where to begin
Internal Gaps: Client didn’t have the in-house AI expertise needed to execute confidently
Without clear direction and a trusted execution partner, the companies competitive edge was slipping, and their CRO clients were beginning to expect more.
WHAT WE DELIVERED: STRATEGIC CLARITY MEETS AI EXECUTION
Digineer moved quickly to bring clarity, capability, and momentum to the companies transformation.
Executive AI Workshop
• Delivered a high-impact 2-hour working session with the CEO and leadership team
• Identified high-value, high-feasibility AI opportunities aligned with business goals and client needs
AI-Powered Operational Intelligence
• Built a proprietary ML algorithm to analyze site-level trial data
• Delivered real-time, personalized insights for hundreds of clinical sites
• Enabled CROs to identify under performing sites, benchmark against peers, and drive rapid improvements
Accelerated Time to Market
• Replaced slow manual processes with predictive AI models
• Shaved significant time off drug trial completion and approval timelines
• Gave CROs the visibility to act—not just react
Modernization That Matters
• Transformed software from a data repository into an AI-powered platform
• Delivered a differentiated, high-value experience CROs could rely on
• Positioned company as a true technology leader in their clinical space
WHAT THIS MEANS: FROM BEHIND THE CURVE TO AHEAD OF THE PACK
The client didn’t just add AI they elevated their platform and the clinical trial experience.
By focusing on strategic impact, pragmatic execution, and measurable value, Digineer helped the client deliver a future-ready platform that CROs now trust to drive faster, cleaner, more consistent trials.
Because the future of clinical research demands more than insight, it demands action.
DIGINEER